An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

NCT00516048 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide

Sponsor

AstraZeneca

Collaborators

[object Object]